ALTIMMUNE, INC. Operating Leases, Rent Expense, Sublease Rentals
ALTIMMUNE, INC. (ALT) reported Operating Leases, Rent Expense, Sublease Rentals of $100.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseSubleaseRentals1 · last filed 2016-11-04
- ALTIMMUNE, INC. operating leases, rent expense, sublease rentals for the quarter ending 2016-09-30 was $0.00.
- ALTIMMUNE, INC. operating leases, rent expense, sublease rentals for the quarter ending 2016-06-30 was -$100.00K.
- ALTIMMUNE, INC. operating leases, rent expense, sublease rentals for the quarter ending 2016-03-31 was $200.00K.
- ALTIMMUNE, INC. operating leases, rent expense, sublease rentals for fiscal 2015 was $200.00K.
| Period end | Operating Leases, Rent Expense, Sublease Rentals 3 month | Operating Leases, Rent Expense, Sublease Rentals 6 month | Operating Leases, Rent Expense, Sublease Rentals 9 month | Operating Leases, Rent Expense, Sublease Rentals 12 month |
|---|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$100.00K derived: sum of 2 quarters · filed 2016-11-04 | $100.00K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $100.00K 10-Q · filed 2016-08-04 | ||
| 2016-03-31 | $200.00K 10-Q · filed 2016-05-09 | |||
| 2015-12-31 | $200.00K 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |